Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
Peter Marks, the Food and Drug Administration (FDA) official pressured to resign over his disagreements with Health and Human ...
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...
“We are confident our well-tolerated vaccine represents an important alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office was put on administrative leave ...